Literature DB >> 1531064

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.

S Nair1, F Zhou, R Reddy, L Huang, B T Rouse.   

Abstract

Effective immunity to many infectious agents, particularly viruses, requires a CD8+ cytotoxic T lymphocyte (CTL) response. Understanding how to achieve CTL induction with soluble proteins is important for vaccine development since such antigens are usually not processed appropriately to induce CTL. In the present report, we have demonstrated that a potent primary CTL response against a soluble protein can be achieved by delivering antigen in pH-sensitive liposomes to dendritic cells (DC) either in vivo or in vitro. Since the pH-sensitive liposome delivery system is efficient and easy to use, the approach promises to be valuable both in the study of basic mechanisms in antigen processing, and as a practical means of immunization.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531064      PMCID: PMC2119126          DOI: 10.1084/jem.175.2.609

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein.

Authors:  R Reddy; F Zhou; L Huang; F Carbone; M Bevan; B T Rouse
Journal:  J Immunol Methods       Date:  1991-08-09       Impact factor: 2.303

Review 2.  Antiviral cytotoxic T lymphocyte induction and vaccination.

Authors:  B T Rouse; S Norley; S Martin
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

3.  The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen.

Authors:  D Su; N Van Rooijen
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

4.  Introduction of soluble protein into the class I pathway of antigen processing and presentation.

Authors:  M W Moore; F R Carbone; M J Bevan
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

5.  A monoclonal antibody specific for mouse dendritic cells.

Authors:  M C Nussenzweig; R M Steinman; M D Witmer; B Gutchinov
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

6.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

7.  Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.

Authors:  F R Carbone; M W Moore; J M Sheil; M J Bevan
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

8.  Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro.

Authors:  S E Macatonia; P M Taylor; S C Knight; B A Askonas
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins.

Authors:  M Crowley; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.

Authors:  L A Morrison; A E Lukacher; V L Braciale; D P Fan; T J Braciale
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  36 in total

1.  In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.

Authors:  C Sedlik; G Dadaglio; M F Saron; E Deriaud; M Rojas; S I Casal; C Leclerc
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 2.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

Review 3.  The next wave of recombinant and synthetic anticancer vaccines.

Authors:  K R Irvine; N P Restifo
Journal:  Semin Cancer Biol       Date:  1995-12       Impact factor: 15.707

4.  Antigen presentation in retroviral vector-mediated gene transfer in vivo.

Authors:  E S Song; V Lee; C D Surh; A Lynn; D Brumm; D J Jolly; J F Warner; S Chada
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 5.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

Review 6.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

7.  Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins.

Authors:  R J Rouse; S K Nair; S L Lydy; J C Bowen; B T Rouse
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

Authors:  N Bhardwaj; A Bender; N Gonzalez; L K Bui; M C Garrett; R M Steinman
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 9.  Enhancing the recognition of tumour associated antigens.

Authors:  N P Restifo; B R Minev; A S Taggarse; B J McFarland; M Wang; K R Irvine
Journal:  Folia Biol (Praha)       Date:  1994       Impact factor: 0.906

10.  Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.

Authors:  J C Bowen; S K Nair; R Reddy; B T Rouse
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.